Interactive Voice Response Telephone Technology for the Treatment of Smoking in Patients With Heart Disease
IVR
An Interactive, Voice Response-Mediated, Follow-up and Triage System for Smoking Cessation in Smokers With Coronary Heart Disease
1 other identifier
interventional
440
1 country
1
Brief Summary
A randomized control trial is planned to evaluate an interactive voice response (IVR) mediated follow-up and triage system, against usual care, to help smokers hospitalized with Coronary Heart Disease (CHD) to quit smoking. The investigators hypothesize that compared to usual care, participants in the IVR group will; a) have a significantly higher 7-day point prevalence abstinence rate at 26 and 52 weeks after hospital discharge, b) will have a higher rate of continuous abstinence at 26 and 52 weeks after hospital discharge, c) will use a greater number of proven effective interventions over time, and d) will develop greater self-efficacy with respect to smoking cessation, over time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable coronary-artery-disease
Started Jul 2006
Typical duration for not_applicable coronary-artery-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2006
CompletedFirst Submitted
Initial submission to the registry
March 19, 2007
CompletedFirst Posted
Study publicly available on registry
March 21, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2011
CompletedResults Posted
Study results publicly available
June 30, 2026
CompletedJune 30, 2026
April 1, 2011
4.6 years
March 19, 2007
May 27, 2026
June 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Continuous Abstinence Rate
Self-reported abstinence from any tobacco product during the time period.
Baseline to 26 weeks
Secondary Outcomes (2)
Continuous Abstinence Rate
27 to 52 weeks
7-day Point-prevalence Abstinence Rates
At weeks 26 and 52.
Study Arms (2)
Interactive Voice Response Group
EXPERIMENTALUsual Care Group
NO INTERVENTIONInterventions
The IVR group will receive a telephone call from the IVR system three, 14, 30, 90, 120 and 150 days after hospital discharge.
Eligibility Criteria
You may qualify if:
- Patient is currently a smoker (greater than 5 cigarettes per day in the month preceding admission);
- Patient is 18 years of age and older;
- Patient is admitted to the in-patient cardiology service at the University of Ottawa Heart Institute (UOHI) for: a) Acute Coronary Syndrome (includes patients admitted for unstable angina or acute myocardial infarction), b) Elective Percutaneous Coronary Intervention (PCI), c) Coronary Artery Bypass Graft (CABG) or d) diagnostic catheterization procedures related to CHD;
- Patient has received automatic referral for smoking cessation counseling;
- Patient is willing to provide informed consent
You may not qualify if:
- Patient is unable to read and understand English;
- Patient lives more than 1.5 hours from UOHI;
- Patient is returning to referring institution/hospital
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Ottawa Heart Institute
Ottawa, Ontario, K1Y4W, Canada
Related Publications (1)
Reid RD, Aitken DA, Mullen KA, McDonnell L, Armstrong A, LeBlanc AG, Slovinec-D'Angelo M, Pipe AL. Automated Telephone Follow-up for Smoking Cessation in Smokers With Coronary Heart Disease: A Randomized Controlled Trial. Nicotine Tob Res. 2019 Jul 17;21(8):1051-1057. doi: 10.1093/ntr/nty108.
PMID: 29800420DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
* participants were not blinded and may have sought other support services * The intervention group received the standard treatment and the intervention, so cannot confirm quit rate on each arm * lower consent rate than expected
Results Point of Contact
- Title
- Dr. Robert Reid
- Organization
- University of Ottawa Heart Institute
Study Officials
- STUDY CHAIR
Robert D Reid, PhD.
University of Ottawa Heart Institute, Minto Prevention and Rehabilitation Centre
- PRINCIPAL INVESTIGATOR
Andrew Pipe, C.M, MD
University of Ottawa Heart Institute, Minto Prevention and Rehabilitation Centre
- PRINCIPAL INVESTIGATOR
Bonnie Quinlan, BSCN
University of Ottawa Heart Institute, Prevention and Rehabilitation Centre
- PRINCIPAL INVESTIGATOR
Heather Sherrard, BSCN, MHA
Ottawa Heart Institute Research Corporation
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Masking Details
- Research Assistants completing follow up for outcome data at weeks 26 and 52 were blinded to the treatment allocation.
- Purpose
- OTHER
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 19, 2007
First Posted
March 21, 2007
Study Start
July 1, 2006
Primary Completion
February 1, 2011
Study Completion
February 1, 2011
Last Updated
June 30, 2026
Results First Posted
June 30, 2026
Record last verified: 2011-04